2. 筋萎縮性側索硬化症
[臨床試験数:508,薬物数:530(DrugBank:146),標的遺伝子数:170,標的パスウェイ数:221

Searched query = "Amyotrophic lateral sclerosis", "ALS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01492686
(ClinicalTrials.gov)
December 201111/12/2011Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral SclerosisEfficacy and Safety Study of MCI-186 for Treatment of the Patients With Amyotrophic Lateral Sclerosis (ALS) 2Amyotrophic Lateral Sclerosis (ALS)Drug: MCI-186;Drug: Placebo;Drug: MCI-186 in open label phaseMitsubishi Tanabe Pharma CorporationNULLCompleted20 Years75 YearsAll137Phase 3Japan